Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 360

1.

Estimating window period blood donations for human immunodeficiency virus Type 1, hepatitis C virus, and hepatitis B virus by nucleic acid amplification testing in Southern Pakistan.

Moiz B, Moatter T, Shaikh U, Adil S, Ali N, Mahar F, Shamsuddin N, Khurshid M.

Transfusion. 2014 Jun;54(6):1652-9. doi: 10.1111/trf.12521. Epub 2014 Jan 3.

PMID:
24383918
2.

Trends in prevalence, incidence, and residual risk of major transfusion-transmissible viral infections in United Arab Emirates blood donors: impact of individual-donation nucleic acid testing, 2004 through 2009.

Al Shaer L, AbdulRahman M, John TJ, AlHashimi A.

Transfusion. 2012 Nov;52(11):2300-9. doi: 10.1111/j.1537-2995.2012.03740.x. Epub 2012 Jun 13.

PMID:
22691239
3.

High throughput screening of 16 million serologically negative blood donors for hepatitis B virus, hepatitis C virus and human immunodeficiency virus type-1 by nucleic acid amplification testing with specific and sensitive multiplex reagent in Japan.

Mine H, Emura H, Miyamoto M, Tomono T, Minegishi K, Murokawa H, Yamanaka R, Yoshikawa A, Nishioka K; Japanese Red Cross NAT Research Group.

J Virol Methods. 2003 Sep;112(1-2):145-51.

PMID:
12951223
4.

Hepatitis B virus testing by minipool nucleic acid testing: does it improve blood safety?

Stramer SL, Notari EP, Krysztof DE, Dodd RY.

Transfusion. 2013 Oct;53(10 Pt 2):2449-58. doi: 10.1111/trf.12213. Epub 2013 Apr 23.

5.

A pilot study for screening blood donors in Taiwan by nucleic acid amplification technology: detecting occult hepatitis B virus infections and closing the serologic window period for hepatitis C virus.

Li L, Chen PJ, Chen MH, Chak KF, Lin KS, Tsai SJ.

Transfusion. 2008 Jun;48(6):1198-206. doi: 10.1111/j.1537-2995.2008.01672.x. Epub 2008 Apr 14.

PMID:
18422856
7.

Routine screening of blood donations at Qingdao central blood bank, China, for hepatitis B virus (HBV) DNA with a real-time, multiplex nucleic acid test for HBV, hepatitis C virus, and human immunodeficiency virus Types 1 and 2.

Yang Z, Xu L, Liu L, Feng Q, Zhang L, Ma W, Saldanha J, Wang M, Zhao L.

Transfusion. 2013 Oct;53(10 Pt 2):2538-44. doi: 10.1111/trf.12159. Epub 2013 Mar 11.

PMID:
23480568
8.

Nucleic acid testing for blood banks: an experience from a tertiary care centre in New Delhi, India.

Agarwal N, Chatterjee K, Coshic P, Borgohain M.

Transfus Apher Sci. 2013 Dec;49(3):482-4. doi: 10.1016/j.transci.2013.03.004. Epub 2013 Mar 28.

PMID:
23541414
9.

[Trends in residual risk of transfusion-transmitted viral infections (HIV, HCV, HBV) in France between 1992 and 2002 and impact of viral genome screening (Nucleic Acid Testing)].

Pillonel J, Laperche S; Groupe "Agents Transmissibles par Transfusion" de la Société française de transfusion sanguine; Etablissement français du sang; Centre de transfusion sanguine des armées.

Transfus Clin Biol. 2004 Apr;11(2):81-6. French.

PMID:
15120104
10.

The first large-scale nucleic acid amplification testing (NAT) of donated blood using multiplex reagent for simultaneous detection of HBV, HCV, and HIV-1 and significance of NAT for HBV.

Ohnuma H, Tanaka T, Yoshikawa A, Murokawa H, Minegishi K, Yamanaka R, Lizuka HY, Miyamoto M, Satoh S, Nakahira S, Tomono T, Murozuka T, Takeda Y, Doi Y, Mine H, Yokoyama S, Hirose T, Nishioka K; Japanese Red Cross NAT Screening Research Group.

Microbiol Immunol. 2001;45(9):667-72.

11.

Evaluation of a multiplex human immunodeficiency virus-1, hepatitis C virus, and hepatitis B virus nucleic acid testing assay to detect viremic blood donors in northern Thailand.

Nantachit N, Thaikruea L, Thongsawat S, Leetrakool N, Fongsatikul L, Sompan P, Fong YL, Nichols D, Ziermann R, Ness P, Nelson KE.

Transfusion. 2007 Oct;47(10):1803-8.

PMID:
17880604
12.

Impact of individual-donation nucleic acid testing on risk of human immunodeficiency virus, hepatitis B virus, and hepatitis C virus transmission by blood transfusion in South Africa.

Vermeulen M, Lelie N, Sykes W, Crookes R, Swanevelder J, Gaggia L, Le Roux M, Kuun E, Gulube S, Reddy R.

Transfusion. 2009 Jun;49(6):1115-25. doi: 10.1111/j.1537-2995.2009.02110.x. Epub 2009 Feb 27.

PMID:
19309474
13.

Blood donation screening for hepatitis B virus markers in the era of nucleic acid testing: are all tests of value?

Stramer SL, Zou S, Notari EP, Foster GA, Krysztof DE, Musavi F, Dodd RY.

Transfusion. 2012 Feb;52(2):440-6. doi: 10.1111/j.1537-2995.2011.03283.x. Epub 2011 Aug 2.

PMID:
21810101
14.

Experience of German Red Cross blood donor services with nucleic acid testing: results of screening more than 30 million blood donations for human immunodeficiency virus-1, hepatitis C virus, and hepatitis B virus.

Hourfar MK, Jork C, Schottstedt V, Weber-Schehl M, Brixner V, Busch MP, Geusendam G, Gubbe K, Mahnhardt C, Mayr-Wohlfart U, Pichl L, Roth WK, Schmidt M, Seifried E, Wright DJ; German Red Cross NAT Study Group.

Transfusion. 2008 Aug;48(8):1558-66. doi: 10.1111/j.1537-2995.2008.01718.x. Epub 2008 May 6.

PMID:
18466173
15.

Residual risk of transfusion-transmitted viral infections in Shenzhen, China, 2001 through 2004.

Shang G, Seed CR, Wang F, Nie D, Farrugia A.

Transfusion. 2007 Mar;47(3):529-39.

PMID:
17319836
16.

Impact of nucleic acid testing for hepatitis B virus, hepatitis C virus, and human immunodeficiency virus on the safety of blood supply in Italy: a 6-year survey.

Velati C, Romanò L, Fomiatti L, Baruffi L, Zanetti AR; SIMTI Research Group.

Transfusion. 2008 Oct;48(10):2205-13. doi: 10.1111/j.1537-2995.2008.01813.x. Epub 2008 Jul 8.

PMID:
18631163
17.

Nationwide nucleic acid amplification testing of hepatitis B virus, hepatitis C virus and human immunodeficiency virus type 1 for blood transfusion and follow-up study of nucleic acid amplification positive donors.

Japanese Red Cross NAT Screening Research Group.

Jpn J Infect Dis. 2000 Jun;53(3):116-23. Erratum in: Jpn J Infect Dis 2000 Oct;53(5):219.

PMID:
10957709
18.

Nucleic acid amplification technology screening for hepatitis C virus and human immunodeficiency virus for blood donations.

Bamaga MS, Bokhari FF, Aboud AM, Al-Malki M, Alenzi FQ.

Saudi Med J. 2006 Jun;27(6):781-7.

PMID:
16758035
19.

[Safe blood in the absence of viral infections due to HBV, HCV and HIV in serological window period in donors].

Contreras AM, Reta CB, Torres O, Celis A, Domínguez J.

Salud Publica Mex. 2011;53 Suppl 1:S13-8. Spanish.

20.

Hepatitis B virus (HBV) DNA screening of blood donations in minipools with the COBAS AmpliScreen HBV test.

Kleinman SH, Strong DM, Tegtmeier GG, Holland PV, Gorlin JB, Cousins C, Chiacchierini RP, Pietrelli LA.

Transfusion. 2005 Aug;45(8):1247-57.

PMID:
16078909

Supplemental Content

Support Center